Top 200 Medicines Annual Report 2019: The king of medicines
Humira’s dominance continues as the world’s top-selling prescription product as the biologic therapy is the first drug to exceed $20 billion in annual global sales.
Featured Posts
2019 Annual Report: Healthcare Communications Agencies Overview – Another Year Of Changes, Growth
The healthcare ad industry continues to thrive and adapt to the new demands for relevance and creativity.
Top 10 Pipelines To Watch: 2019 Annual Report
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.
Annual Report 2019: State of the Bio Industry
This annual compilation reviews new developments, trends and outlooks in areas such as biotechnology, biosimilars, biopharmaceuticals, biologics, biomarkers and biosimulation.
PulseCX: 2019
PulseCX is a full-service, independent, mid-sized healthcare marketing agency located just outside Philadelphia. PulseCX specializes in optimizing the customer experience (CX) for pharmaceutical brands, medical devices, and OTC products.
2019 Annual Report: Healthcare Communications Agencies Overview – Another Year Of Changes, Growth
The healthcare ad industry continues to thrive and adapt to the new demands for relevance and creativity.
Top 10 Pipelines To Watch: 2019 Annual Report
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.
Healthcare Agency Roundtable 2018
Leadership representing the 2018 Manny Award agency and network winners and finalists share their views on various healthcare industry trends and developments.
2018 Annual Report: Top 50 Companies – Looking to future challenges
The top pharmaceutical companies are trying to proactively tackle, through shifts in R&D strategy and other tactics, the healthcare demands of the future.
Company of the Year 2018 — Johnson & Johnson: Defining the future of healthcare
The executive management team of this “132-year-old startup” company is excited about a future that lies beyond the intersection of science and technology.
Top 200 Medicines Annual Report 2018: Blockbusters thriving despite tumultuous climate
There were as many billion-dollar brands in 2017 as there have been in any other calendar year despite the cratering effects of massive patent cliffs in 2012 and 2015.
Annual Report 2018: State of the Bio Industry
This yearly review analyzes recent developments, trends and outlooks in the areas of biotechnology, biosimilars, biopharmaceuticals, biologics, biomarkers and biobanks.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com. 
August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!